MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$1,613,000
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Collaboration agreement revenue
-
-
0
0
Research and development
893,000
1,235,000
1,128,000
936,000
Selling, general and administrative
730,000
1,031,000
885,000
552,000
Total costs and expenses
1,623,000
2,266,000
2,013,000
1,488,000
Operating loss
-1,623,000
-2,266,000
-2,013,000
-1,488,000
Total other income, net
10,000
7,000
29,000
5,000
Net loss
-1,613,000
-2,259,000
-1,984,000
-1,483,000
Basic EPS
-0.13
-0.21
-0.186
-0.24
Diluted EPS
-
-0.21
-
-
Basic Average Shares
12,093,268
10,812,419
10,694,424
6,277,848
Diluted Average Shares
-
10,812,419
-
-
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$1,613,000
(21.28%↑ Y/Y)
Total other income,
net
$10,000
(400.00%↑ Y/Y)
Operating loss
-$1,623,000
(20.87%↑ Y/Y)
Total costs and
expenses
$1,623,000
(-20.87%↓ Y/Y)
Research and development
$893,000
(-34.72%↓ Y/Y)
Selling, general and
administrative
$730,000
(6.88%↑ Y/Y)
Buy us a coffee
BioCardia, Inc. (BCDA)
BioCardia, Inc. (BCDA)